This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...